Details for New Drug Application (NDA): 211719
✉ Email this page to a colleague
The generic ingredient in ETHACRYNIC ACID is ethacrynic acid. There are thirteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
Summary for 211719
Tradename: | ETHACRYNIC ACID |
Applicant: | Lupin Ltd |
Ingredient: | ethacrynic acid |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211719
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 211719
Suppliers and Packaging for NDA: 211719
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211719 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-159 | 68180-159-01 | 100 TABLET in 1 BOTTLE (68180-159-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Sep 6, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription